Insiders Cash Out, Health CEO Buys Dip

Insider filings from the past two weeks reveal a clear split. Executives at several companies are selling near highs. Others are putting fresh cash to work.

The most eye-catching buying came from ELV. CEO Gail Boudreaux filed on July 17 that she purchased $1M worth of shares at around $368. The Independent Chairman also bought $366,000 in the same session. Both trades were filed the same day they occurred. That kind of coordinated C-suite buying is rare and signals confidence in the stock.

Over at LQDA, the story runs in reverse. Venture-backed board members unloaded more than $24M in shares across July 21–23. Canaan VIII LP alone dumped over $17M. The filings hit July 22–24. The stock was trading near $89 — close to multi-year highs.

MS CFO Sharon Yeshaya filed on July 17 that she sold $3.4M worth of stock just days after the bank posted strong earnings. Fellow executive Michael Pizzi sold another $5.2M in the same period.

Three insiders at WAB filed sales of $3.3M combined on July 27. The CTO alone accounted for over $2.1M. All trades occurred July 24 near the $300 mark.

This is not financial advice.